Markets›PBM

Psyence Biomedical Ltd.

PBM · NASDAQ-CM
5.67
+0.11 (+1.89%)
Last price from Nasdaq, delayed

What Psyence Biomedical Ltd. does

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Key facts

IndustryPharmaceutical Preparations
Employees12
HeadquartersTORONTO
Incorporated inA6
Listed onNasdaq, Nasdaq
Listed sinceJan 26, 2024
Fiscal year endsMarch 31
SEC filer categoryNon-accelerated filer<br>Emerging growth company
Websitepsyence.com
SEC company number (CIK)1985062

Company description from Polygon.io. Industry, address and filing details from SEC EDGAR.